Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -18.69%140.71M | -2.16%37.8M | -13.29%40.32M | -7.87%24.31M | -37.78%38.29M | 23.81%173.05M | 15.05%38.64M | 2.02%46.49M | 4.80%26.38M | 73.64%61.53M |
Net income from continuing operations | -11.74%72.77M | -76.87%4.21M | 14.23%27.6M | 1.20%22.68M | 3.42%18.28M | -5.75%82.45M | -18.86%18.2M | -12.11%24.16M | 15.32%22.41M | -2.47%17.67M |
Operating gains losses | 56.60%249K | -126.76%-19K | 583.33%205K | --100K | ---37K | 330.43%159K | 192.21%71K | -79.59%30K | ---- | ---- |
Depreciation and amortization | 8.60%51.36M | 10.07%13.37M | 7.43%13.1M | 6.77%12.4M | 10.14%12.49M | 8.89%47.29M | 8.53%12.14M | 9.07%12.2M | 10.16%11.62M | 7.81%11.34M |
Deferred tax | -14,417.65%-9.74M | ---- | ---- | ---- | ---- | -98.00%68K | ---- | ---- | ---- | ---- |
Other non cash items | -213.87%-394K | -4,733.33%-417K | -65.00%7K | 60.00%8K | -97.44%8K | -77.68%346K | -98.07%9K | -94.99%20K | -98.47%5K | -12.85%312K |
Change In working capital | -47.62%18.37M | 409.83%28.12M | -134.95%-2.74M | -41.34%-12.75M | -81.35%5.73M | 2,689.44%35.06M | 199.95%5.52M | 56.61%7.84M | -48.65%-9.02M | 487.65%30.73M |
-Change in receivables | -95.40%982K | -73.74%161K | 45.27%-602K | 30.43%-5.8M | -76.07%7.22M | 1,812.71%21.37M | 2,143.33%613K | -290.07%-1.1M | -12,543.28%-8.34M | 2,116.52%30.19M |
-Change in inventory | -2,903.57%-1.68M | -280.70%-1.64M | 2,544.44%440K | -214.59%-733K | -60.32%248K | 85.96%-56K | 58.01%-430K | -101.55%-18K | 67.77%-233K | 234.22%625K |
-Change in prepaid assets | 116.64%409K | 59.83%-1.23M | -57.17%-1.45M | 124.14%1.44M | 85.79%1.65M | -149.54%-2.46M | -289.21%-3.07M | 36.90%-920K | -13.24%642K | 70.25%887K |
-Change in payables and accrued expense | 15.10%18.66M | 267.02%30.83M | -111.45%-1.13M | -601.01%-7.66M | -248.10%-3.39M | 1,591.26%16.21M | 328.45%8.4M | 131.81%9.88M | 51.42%-1.09M | -268.34%-973K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -18.69%140.71M | -2.16%37.8M | -13.29%40.32M | -7.87%24.31M | -37.78%38.29M | 23.81%173.05M | 15.05%38.64M | 2.02%46.49M | 4.80%26.38M | 73.64%61.53M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 14.52%-43.79M | 43.36%-9.41M | 58.70%-3.72M | -22.56%-12.78M | -17.72%-17.88M | -6.79%-51.23M | -123.16%-16.61M | -69.91%-9M | 20.87%-10.43M | 31.12%-15.19M |
Net PPE purchase and sale | 3.21%-47.43M | 31.36%-11.56M | 45.35%-4.9M | -58.48%-13.35M | -19.25%-17.62M | -24.14%-49.01M | -109.15%-16.84M | -89.43%-8.96M | 29.08%-8.43M | 0.25%-14.78M |
Net other investing changes | 264.12%3.65M | 813.14%2.16M | 3,050.00%1.18M | 128.51%571K | 36.96%-261K | 73.85%-2.22M | -61.37%236K | 92.95%-40K | -54.20%-2M | 94.28%-414K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 14.52%-43.79M | 43.36%-9.41M | 58.70%-3.72M | -22.56%-12.78M | -17.72%-17.88M | -6.79%-51.23M | -123.16%-16.61M | -69.91%-9M | 20.87%-10.43M | 31.12%-15.19M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 30.46%-81.53M | 28.38%-9.02M | 20.55%-30.73M | -14.51%-17.5M | 52.10%-24.28M | -35.47%-117.24M | 38.60%-12.59M | -2.54%-38.67M | -4.94%-15.28M | -268.35%-50.69M |
Net issuance payments of debt | -266.67%-5.5M | -180.00%-7M | 51.52%-16M | 275.00%17.5M | --0 | 98.19%-1.5M | 87.50%-2.5M | 13.16%-33M | 33.33%-10M | 540.00%44M |
Net common stock issuance | -1,092.68%-59.97M | 101.25%63K | ---9.68M | ---30.78M | ---19.57M | 22.65%-5.03M | ---5.03M | --0 | --0 | --0 |
Cash dividends paid | 80.26%-22.27M | 3.55%-5.52M | 4.02%-5.51M | 3.27%-5.55M | 94.06%-5.68M | ---112.82M | ---5.73M | ---5.74M | ---5.74M | ---95.61M |
Proceeds from stock option exercised by employees | 219.51%8.22M | 273.94%3.44M | 1,261.45%2.44M | 191.05%1.33M | -0.79%1.01M | -73.85%2.57M | -76.47%921K | -36.97%179K | 4.81%458K | -80.50%1.02M |
Net other financing activities | -333.84%-2.01M | --0 | -1,711.93%-1.98M | --0 | 61.62%-38K | 93.26%-464K | 94.20%-256K | ---109K | --0 | 95.99%-99K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 30.46%-81.53M | 28.38%-9.02M | 20.55%-30.73M | -14.51%-17.5M | 52.10%-24.28M | -35.47%-117.24M | 38.60%-12.59M | -2.54%-38.67M | -4.94%-15.28M | -268.35%-50.69M |
Net cash flow | ||||||||||
Beginning cash position | 11.82%43.36M | 16.10%39.38M | -4.54%33.51M | 14.68%39.48M | 11.82%43.36M | 15.67%38.78M | 2.35%33.92M | 14.78%35.1M | 3.86%34.43M | 15.67%38.78M |
Current changes in cash | 236.08%15.4M | 105.23%19.38M | 596.79%5.87M | -991.94%-5.98M | 10.85%-3.88M | -12.77%4.58M | 67.43%9.44M | -146.19%-1.18M | 126.08%670K | -1,053.58%-4.35M |
End cash Position | 35.51%58.76M | 35.51%58.76M | 16.10%39.38M | -4.54%33.51M | 14.68%39.48M | 11.82%43.36M | 11.82%43.36M | 2.35%33.92M | 14.78%35.1M | 3.86%34.43M |
Free cash flow | -24.80%93.28M | 20.39%26.24M | -5.63%35.42M | -39.00%10.95M | -55.80%20.67M | 23.68%124.04M | -14.63%21.8M | -8.10%37.53M | 35.08%17.96M | 126.71%46.76M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |